In addition to E33 upregulation in T2D, treatments with high glucose and palmitic acid increased its expression in macrophages from db/+ mice, which corresponded with elevated levels of inflammatory genes. The gene discussed is NDUFAF3; the disease is type 2 diabetes mellitus.